MYP_145458
Basic Information
Ramucirumab
Anticancer
Anticancer Anti-angiogenic activity VEGFR targeting Anti-VEGFR2 cross
Enzyme modulation Receptor tyrosine kinase inhibition VEGFR inhibition cross
Enzyme modulation Receptor tyrosine kinase inhibition VEGFR inhibition Anti-VEGFR2 cross
Wound healing/Regeneration Angiogenesis modulation Anti-angiogenic
Standard
60 amino acids
C285H434N74O88S2
Standard
Sequence
EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYY
Physicochemical Analysis
6369.07 Da
9.00
1.82
1.63
0.0304
0.02
0.48
0.17
50.13
74.67
0.1333
16960.00
16960.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
2601.39
-31.40
95.0
92.0
204.0
449.0
12.0
63.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0245259 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Monoclonal antibody
9606
Structure & Mods
linear multidomain protein biologic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Anti-angiogenic Anticancer Monoclonal antibody Anti-VEGFR2
15 d